Home › Lung Diseases › New Jersey › Edison
Lung Diseases clinical trials in Edison, NJ
3 studies for Lung Diseases are looking for participants at sites in and around Edison (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
RecruitingPhase 2
- Rutgers, Robert Wood Johnson Medical School, New Brunswick · 3 mi away
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center - Basking Ridge, Basking Ridge · 15 mi away
TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics
RecruitingHealthy volunteers welcome
- Rutgers Cancer Institute, New Brunswick · 3 mi away
About Lung Diseases
Lung diseases are disorders or infections that affect the lungs and cause breathing problems. Some can lead to respiratory failure. Find out more about prevention, living with lung diseases, and treatment.
More about Lung Diseases on MedlinePlus
Lung Diseases trials in other cities
- Houston, TX16 studies
- Boston, MA14 studies
- Durham, NC13 studies
- New York City, NY13 studies
- Pittsburgh, PA11 studies
- Dallas, TX10 studies
- Los Angeles, CA10 studies
- Ann Arbor, MI10 studies
- Miami, FL10 studies
- Columbus, OH10 studies
- Chicago, IL9 studies
- Washington, DC9 studies
Other studies in Edison
- Breast Cancer70 studies
- Non-Small Cell Lung Cancer50 studies
- Cancer (all types)33 studies
- Prostate Cancer29 studies
- Colorectal Cancer25 studies
- Lung Cancer25 studies
- Bladder Cancer23 studies
- Multiple Myeloma21 studies
- Metastatic Cancer20 studies
- Endometrial Cancer20 studies
- Acute Myeloid Leukemia20 studies
- Ovarian Cancer19 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.